Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myocardial structural and functional changes in cardiac amyloidosis: insights from a prospective observational patient registry.
Duca F, Rettl R, Kronberger C, Binder C, Mann C, Dusik F, Schrutka L, Dalos D, Öztürk B, Dachs TM, Cherouny B, Camuz Ligios L, Agis H, Kain R, Koschutnik M, Donà C, Badr-Eslam R, Kastner J, Beitzke D, Loewe C, Nitsche C, Hengstenberg C, Kammerlander AA, Bonderman D. Duca F, et al. Among authors: schrutka l. Eur Heart J Cardiovasc Imaging. 2023 Dec 21;25(1):95-104. doi: 10.1093/ehjci/jead188. Eur Heart J Cardiovasc Imaging. 2023. PMID: 37549339 Free PMC article.
Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathy.
Rettl R, Mann C, Duca F, Dachs TM, Binder C, Ligios LC, Schrutka L, Dalos D, Koschutnik M, Donà C, Kammerlander A, Beitzke D, Loewe C, Charwat-Resl S, Hengstenberg C, Kastner J, Eslam RB, Bonderman D. Rettl R, et al. Among authors: schrutka l. Eur Heart J Cardiovasc Imaging. 2022 Jun 1;23(6):767-780. doi: 10.1093/ehjci/jeab226. Eur Heart J Cardiovasc Imaging. 2022. PMID: 34788394
Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy.
Rettl R, Wollenweber T, Duca F, Binder C, Cherouny B, Dachs TM, Camuz Ligios L, Schrutka L, Dalos D, Beitzke D, Loewe C, Badr Eslam R, Kastner J, Hacker M, Bonderman D. Rettl R, et al. Among authors: schrutka l. Eur Heart J Cardiovasc Imaging. 2023 Jul 24;24(8):1019-1030. doi: 10.1093/ehjci/jead030. Eur Heart J Cardiovasc Imaging. 2023. PMID: 36881774 Free PMC article.
Machine Learning Enables Prediction of Cardiac Amyloidosis by Routine Laboratory Parameters: A Proof-of-Concept Study.
Agibetov A, Seirer B, Dachs TM, Koschutnik M, Dalos D, Rettl R, Duca F, Schrutka L, Agis H, Kain R, Auer-Grumbach M, Binder C, Mascherbauer J, Hengstenberg C, Samwald M, Dorffner G, Bonderman D. Agibetov A, et al. Among authors: schrutka l. J Clin Med. 2020 May 3;9(5):1334. doi: 10.3390/jcm9051334. J Clin Med. 2020. PMID: 32375287 Free PMC article.
Convolutional Neural Networks for Fully Automated Diagnosis of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging.
Agibetov A, Kammerlander A, Duca F, Nitsche C, Koschutnik M, Donà C, Dachs TM, Rettl R, Stria A, Schrutka L, Binder C, Kastner J, Agis H, Kain R, Auer-Grumbach M, Samwald M, Hengstenberg C, Dorffner G, Mascherbauer J, Bonderman D. Agibetov A, et al. Among authors: schrutka l. J Pers Med. 2021 Dec 1;11(12):1268. doi: 10.3390/jpm11121268. J Pers Med. 2021. PMID: 34945740 Free PMC article.
Impact of Tafamidis and Optimal Background Treatment on Physical Performance in Patients With Transthyretin Amyloid Cardiomyopathy.
Badr Eslam R, Öztürk B, Rettl R, Capelle CDJ, Qin H, Binder C, Dachs TM, Camuz Ligios L, Duca F, Dalos D, Schrutka L, Alasti F, Kastner J, Vila G, Bonderman D. Badr Eslam R, et al. Among authors: schrutka l. Circ Heart Fail. 2022 Jul;15(7):e008381. doi: 10.1161/CIRCHEARTFAILURE.121.008381. Epub 2022 Jun 29. Circ Heart Fail. 2022. PMID: 35766028
Impact of tafamidis on myocardial strain in transthyretin amyloid cardiomyopathy.
Rettl R, Duca F, Binder C, Dachs TM, Cherouny B, Camuz Ligios L, Mann C, Schrutka L, Dalos D, Charwat-Resl S, Badr Eslam R, Kastner J, Bonderman D. Rettl R, et al. Among authors: schrutka l. Amyloid. 2023 Mar;30(1):127-137. doi: 10.1080/13506129.2022.2131385. Epub 2022 Oct 17. Amyloid. 2023. PMID: 36251806
Cardiac amyloidosis: a significant blind spot of the H2FPEF score.
Duca F, Rettl R, Binder C, Dusik F, Schrutka L, Dalos D, Öztürk B, Capelle CD, Qin H, Dachs TM, Camuz Ligios L, Agis H, Kain R, Hengstenberg C, Badr-Eslam R, Kastner J, Bonderman D. Duca F, et al. Among authors: schrutka l. Panminerva Med. 2023 Dec;65(4):491-498. doi: 10.23736/S0031-0808.22.04649-3. Epub 2023 Feb 15. Panminerva Med. 2023. PMID: 36789997 Free article.
36 results